EEF1A1P20

Across TCGA pan-cancer cohorts, EEF1A1P20 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of EEF1A1P20’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where EEF1A1P20 RNA is repressed in tumor relative to normal tissue. In most cancer types EEF1A1P20 is over-expressed in tumor, although a few such as PAAD and KICH show the opposite, repressed pattern.

PAAD, COAD, and THCA are the cancer types where EEF1A1P20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1A1P20 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.100	.009	4	view →
COAD	All	All	+0.061	.027	3	view →
THCA	All	II,III,IV	+0.025	.002	3	view →
KICH	All	II,III,IV	−0.029	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

EEF1A1P20–PAAD

Open the PAAD breakdown →